Medicare Enrolled
Dr. Ahmad Alturjuman, M.D., F.A.C.C.
Optician · Riverside, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alturjuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alturjuman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alturjuman
Dr. Ahmad Alturjuman is an optician specialist in Riverside, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alturjuman performed 2,134 Medicare services across 1,233 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alturjuman received a total of $17,356 from 51 pharmaceutical and/or device companies across 905 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alturjuman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 35% volume in CA
$17,356 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,134
Medicare services
Top 35% in CA for optician
1,233
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~107 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
750 | $97 | $180 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
553 | $96 | $165 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
203 | $153 | $611 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
162 | $139 | $320 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
72 | $10 | $50 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
70 | $63 | $100 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
56 | $11 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $124 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $140 | $220 |
| Cardiac catheterization | 34 | $188 | $799 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
32 | $54 | $112 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
31 | $11 | $100 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
28 | $77 | $135 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
21 | $399 | $900 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
16 | $160 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
11 | $43 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.2% high complexity
2.7% medium
79.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,356
Total received (2018-2024)
Avg $2,479/year across 7 years
Top 9% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
905
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,072 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$284 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,572
2023
$3,217
2022
$2,071
2021
$2,407
2020
$1,581
2019
$2,026
2018
$2,483
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$703
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$445
Novartis Pharmaceuticals Corporation
$435
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Lexicon Pharmaceuticals, Inc.
$200
Merck Sharp & Dohme LLC
$195
Kiniksa Pharmaceuticals International, plc
$188
Novo Nordisk Inc
$188
PFIZER INC.
$186
BIOTRONIK INC.
$155
Janssen Pharmaceuticals, Inc
$133
Edwards Lifesciences Corporation
$69
Kestra Medical Technology Services, Inc.
$49
Medtronic, Inc.
$49
AstraZeneca Pharmaceuticals LP
$45
Acist Medical Systems, Inc.
$45
Amgen Inc.
$42
Lilly USA, LLC
$35
SANOFI-AVENTIS U.S. LLC
$30
E.R. Squibb & Sons, L.L.C.
$30
SCPHARMACEUTICALS INC.
$25
Baxter Healthcare
$23
Esperion Therapeutics, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$20
Boston Scientific Corporation
$18
Top 3 companies account for 44.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$2,111
Janssen Pharmaceuticals, Inc
$1,815
Novartis Pharmaceuticals Corporation
$1,696
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,047
E.R. Squibb & Sons, L.L.C.
$853
PFIZER INC.
$833
Boehringer Ingelheim Pharmaceuticals, Inc.
$805
AstraZeneca Pharmaceuticals LP
$784
ABIOMED
$708
SANOFI-AVENTIS U.S. LLC
$664
Amgen Inc.
$616
Merck Sharp & Dohme LLC
$542
Gilead Sciences, Inc.
$465
BIOTRONIK INC.
$446
Esperion Therapeutics, Inc.
$359
Medtronic Vascular, Inc.
$283
Medtronic, Inc.
$280
Novo Nordisk Inc
$229
Lexicon Pharmaceuticals, Inc.
$216
SCPHARMACEUTICALS INC.
$212
Cardinal Health 200, LLC
$204
Kiniksa Pharmaceuticals International, plc
$188
BOSTON SCIENTIFIC CORPORATION
$175
Kestra Medical Technology Services, Inc.
$161
NOVARTIS PHARMACEUTICALS CORPORATION
$160
CVRx, Inc.
$159
Actelion Pharmaceuticals US, Inc.
$151
ARALEZ PHARMACEUTICALS US INC.
$124
La Jolla Pharmaceutical Company
$118
Lilly USA, LLC
$115
Philips Electronics North America Corporation
$96
Boston Scientific Corporation
$82
Merck Sharp & Dohme Corporation
$81
Edwards Lifesciences Corporation
$69
AngioDynamics, Inc.
$62
Allergan Inc.
$53
Astellas Pharma US Inc
$45
Acist Medical Systems, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
Alnylam Pharmaceuticals Inc.
$44
Chiesi USA, Inc.
$30
Kiniksa Pharmaceuticals, Ltd.
$25
Daiichi Sankyo Inc.
$25
Baxter Healthcare
$23
ATRICURE, INC.
$19
CORDIS US CORP.
$19
Cardiovascular Systems Inc.
$17
Inari Medical, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
Braemar Manufacturing, LLC
$16
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ACCOLADE · AMVIA EDGE · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Adempas · Arcalyst · Assure WCD · Azure · BRILINTA · BYSTOLIC · BYVALSON · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLARIA MRI QUAD CRT-D SURESCAN · COBALT DR MRI SURESCAN · COROFLOW · CVI Consumables · CVI Systems · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · Claria MRI · Compia MRI · Confirm Rx · Corlanor · Coronary Orbital Atherectomy System · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edora · EnSite X · Evera · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GIAPREZA · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Impella · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LifeVest · MICRA · MOUNJARO · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · MitraClip System · NEXLETOL · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · RELIANCE 4FRONT · RESONATE · Repatha · Reveal LINQ · Rybelsus · S · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULICITY · UPTRAVI · VERQUVO · VYNDAMAX · VenaCure 1470 Pro · Visia AF · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIENCE SKYPOINT · ZEPHYR · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in CA.
Geographic Context
Opticians within 10 mi
250
Per 100K population
10.2
County median income
$89,672
Nearest hospital
PACIFIC GROVE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alturjuman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alturjuman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Alturjuman performed 750 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alturjuman receive payments from pharmaceutical companies?
Yes. Dr. Alturjuman received a total of $17,356 from 51 companies across 905 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alturjuman's costs compare to other opticians in Riverside?
Dr. Alturjuman's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alturjuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Riverside
Browse opticians in Riverside ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology